Skip to main content
. 2022 Mar 2;17(1):37. doi: 10.1007/s11657-022-01069-x

Table 3.

Data of the COVID-19 patients

Patient Age (years) Origin Fever Therapy Vitamin D supplementation Comorbidities Fractures Severe osteoporosis Hospitalization Death Serum 25-OH- Vitamin D (ng/ml)
#1 87 AV2 Yes Denosumab Yes HT No Yes No No 25
#2 79 AV2 Yes Denosumab Yes - V, F Yes No No 22
#3 64 AV2 Yes IVBP Yes HT No No No No 29
#4 81 AV2 No Denosumab Yes - No No Yes No 19
#5 80 AV2 Yes Denosumab No DMHTHeart diseaseHTC No No Yes No 18
#6 70 AV2 Yes Denosumab Yes HT No No Yes No 20
#7 76 AV2 Yes Denosumab Yes HTC V, O No Yes No 26
#8 87 AV3 Yes IVBP Yes HTHTC V, O Yes Yes No 18
#9 89 AV2 Yes Denosumab Yes HTHeart disease V, O Yes Yes Yes 12
#10 86 AV2 Yes Denosumab Yes - V, O Yes Yes Yes 18

IVBP: intravenous bisphosphonates; V: vertebral; F: femoral; O: Other sites; HT: hypertension; DM: diabetes mellitus; HTC: hormone therapy for cancer